The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

One of the key findings in recent studies is the role of glucagon-like peptide-1 (GLP-1) in postprandial hypoglycemia. After bariatric surgery, the body often experiences an exaggerated release of ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

MBX Biosciences, Inc.’s MBX share price has dipped by 14.00%, which has investors questioning if this is right time to buy.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The search for effective weight loss solutions has led to countless diet trends, fitness regimens, and medical interventions.

Bariatric surgery is currently the most ... treatment of diabetes and obesity is currently limited. The glucagon-like peptide-1 receptor agonists improve glycemia and induce a modest weight ...

To qualify for hip replacement surgery, she needed to lose 100 ... But then Golden turned to glucagon-like peptide 1 (GLP-1) receptor agonists, and they delivered. Leslie Golden, MD, MPH, DABM ...

MBX 1416 is the company’s investigational long-acting glucagon-like peptide 1 (GLP-1) receptor antagonist, being developed for Post-Bariatric ... types of weight loss surgery.